Reimagining the FDA’s Role in Digital Medicine

In addition to evaluating the
safety of software as a medical device (SaMD), the agency needs to devote more
resources to evaluating its efficacy and quality.

John Halamka, M.D., president, Mayo
Clinic Platform, and Paul Cerrato, senior research analyst and communications
specialist, Mayo…